Stockreport

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials

LENZ Therapeutics, Inc.  (LENZ) 
PDF  Conference call and webcast on Wednesday, April 3, 2024, at 8:00 a.m. EST SAN DIEGO--(BUSINESS WIRE)--LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company [Read more]